Biobanks are diverse processing and storage facilities that maintain biospecimens. These stored biological materials can be used for drug development and discovery efforts, precision medicine studies, biomarker-based preclinical research, and more. Increasingly, biobanks are also storing stem cell lines, such as induced pluripotent stem cell lines that are being derived from both healthy and diseased donors. Biobanks can also contain cord blood units collected from newborns, as well as associated tissues that may contain stem cell and progenitor cells, such as umbilical cord blood tissue or placental tissue. [Read more…]
Top 10 Most Shared Stem Cell Articles of the Past 12 Months
Social Analytics Reveal Key Findings about Stem Cell Article Popularity
The field of stem cell research has boomed over the past twelve months, bringing to light new ideas for treatments and applications. Here at BioInformant, we strive to do our best to provide you with the most up to date information related to the industry. As a supplement to our monthly round-ups, we thought it would be important to share the top ten most shared stem cell articles from the past year.
[Read more…]
Did you know that BioInformant is the fastest growing stem cell account on Twitter?
Did you know that BioInformant (@StemCellMarket) is the fastest growing stem cell account on Twitter? Â Check out our recent Twitter analytics to see our organic followers for the past 28 days.
Or, click here to follow us on Twitter and instantly get critical stem cell and cord blood market news, right to your feed.  It’s the only site through which we release all of our free and premium (paid) stem cell market news. [Read more…]
Trends, Influencers, and Leaders in Stem Cells and Cord Blood
We’ve posted new content about stem cells and cord blood that I’m excited to share it with you. Â Let me know what you think!
Do You Know the Top 5 iPS Cell Influencers (Right Now)?
This article considers five of the most influential people operating within the iPS cell marketplace right now. These individuals are renowned industry experts, innovative thought leaders, and of course, highly-sought after speakers, advisers, and board members. Their individual opinions on iPS cell topics can substantially alter public perception…
*Ocata Therapeutics also covered this iPS cell article in an October 3rd press release. Check it out.
CDI, a FUJIFILM company, Announces Launch of World’s Largest Public Stem Cell Bank
On September 1st, Cellular Dynamics International, a FUJIFILM company, announced news that reverberated throughout the stem cell community. The company launched the world’s largest publicly available stem cell bank, the California Institute for Regenerative Medicine (CIRM) hPSC Repository, and the availability of the first 300 iPS cell lines. [Read more…]
3 Bullet Thursday | Stem Cells (Sept 10, 2015)
Stay alert to the latest and greatest on stem cells.  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on interesting and important events within the world of stem cells.
(1) Do you know the stem cell company that is billionaire Peter Thiel’s largest investment ever in a single company? When a guy worth $3.3 BILLION goes “all in,” you have to take notice.
(2) Announced just two days ago, this news release from the U.S. House is arguably the most important stem cell funding announcement of 2015. Absolutely awesome news. [Read more…]
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- 24
- Next Page »